Symptomatic burden of COPD for patients receiving dual or triple therapy

Symptomatic burden of COPD for patients receiving dual or triple therapy

Stephanie Chen,1 Mark Small,2 Leandro Lindner,3 Xiao Xu1,4 1Health Economics and Payer Analytics, AstraZeneca, Gaithersburg, MD, USA; 2Respiratory, Adelphi Real World, Bollington, UK; 3Global Payer Evidence and Pricing, AstraZeneca, Cambridge, UK; 4Global Payer Evidence and Pricing, AstraZeneca, Ga...

Full description

Bibliographic Details
Main Authors: Chen S, Small M, Lindner L, Xu X
Format: Article
Language:English
Published: Dove Medical Press 2018-04-01
Series:International Journal of COPD
Subjects:
COPD
symptom burden
triple therapy
dual therapy
Online Access:https://www.dovepress.com/symptomatic-burden-of-copd-for-patients-receiving-dual-or-triple-thera-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/symptomatic-burden-of-copd-for-patients-receiving-dual-or-triple-thera-peer-reviewed-article-COPD

Similar Items